docs-200800v6form_8kfrx2012a.htm - Generated by SEC Publisher for SEC Filing

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
__________________________________________ 

 

Pursuant to Section 13 OR 15 (d) of The Securities Exchange Act of 1934

 

August 15, 2012
Date of Report (Date of earliest event reported)

 

    FOREST LABORATORIES, INC.    
(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction
of incorporation)

1-5438
(Commission
File Number)

11-1798614
(IRS Employer
Identification No.)

 

 

 

909 Third Avenue
New York, New York
(Address of principal executive offices)

 

10022-4731
(Zip Code)

 

(212) 421-7850
(Registrant's telephone number, including area code)

                                                None                                             
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[ ]    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

The 2012 Annual Meeting of Stockholders (“2012 Annual Meeting”) of Forest Laboratories, Inc. (the “Company”) was held on August 15, 2012, where the Company’s stockholders voted on the following four proposals:

1.      The election of ten director nominees to serve as members of the Company’s board of directors until the Company’s next Annual Meeting of Stockholders or until his or her successor has been elected or appointed (Proposal 1); 

2.      The approval (on an advisory basis) of the compensation of the Company’s named executive officers, as disclosed in the Company’s definitive proxy statement filed on July 9, 2012 for the 2012 Annual Meeting (the “Proxy Statement”) pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the 2012 Summary Compensation Table and the tabular disclosure regarding such compensation and the accompanying narrative disclosure (Proposal 2); 

3.      The ratification of the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2013 (Proposal 3); and

4.      A stockholder proposal requesting that the Board of Directors of the Company (the “Board”) amend the Company’s Bylaws to allow stockholders to nominate director candidates for inclusion in the Company’s proxy materials.

A fifth matter scheduled to be voted upon at the 2012 Annual Meeting and described in the Proxy Statement was a stockholder proposal submitted by Icahn Capital LP and certain affiliated entities, which are a group of hedge funds led by Carl Icahn (collectively, the “Icahn Group”) that would repeal any provision of the Company’s Bylaws in effect at the time of the 2012 Annual Meeting that was not included in the Company’s Bylaws as publicly filed prior to June 18, 2012.  As no amendments have been made to the Company’s Bylaws as publicly filed prior to June 18, 2012, a representative of the Icahn Group agreed to withdraw the proposal on behalf of the Icahn Group, and the Icahn Group proposal was not included in the matters voted upon at the 2012 Annual Meeting.

A preliminary voting report was produced by IVS Associates, Inc. (“IVS”), the independent inspector of elections for the 2012 Annual Meeting, certifying the following results.  These results are only preliminary and are subject to change.  The Company will file an amendment to this Current Report on Form 8-K to disclose the final results within four business days after they are known.

The preliminary voting totals were as follows:

Proposal 1 - Election of Directors. Each of the following ten director nominees were elected by a plurality of votes as directors for terms expiring at the Company’s next Annual Meeting of Stockholders, or until his or her successor has been elected or appointed:  Howard Solomon, Nesli Basgoz, M.D., Christopher J. Coughlin, Kenneth E. Goodman, Pierre Legault, Gerald M. Lieberman, Lawrence S. Olanoff, M.D., Ph.D., Lester B. Salans, M.D., Brenton L. Saunders and Peter J. Zimetbaum, M.D. 

 


 

 

The preliminary voting results from the 2012 Annual Meeting as reported by IVS are provided below.  In addition, IVS has advised the Company that there were no broker non-votes for Proposal 1.

Name

For

Withheld

Howard Solomon

192,428,946

34,177,256

Nesli Basgoz, M.D.

195,096,207

31,509,995

Christopher J. Coughlin

195,269,038

31,337,164

Dan L. Goldwasser

104,423,584

4,310,965

Kenneth E. Goodman

120,285,741

4,153,828

Gerald M. Lieberman

195,093,139

31,513,063

Lawrence S. Olanoff, M.D., Ph.D.

122,960,337

1,479,232

Lester B. Salans, M.D.

107,675,795

1,058,754

Brenton L. Saunders

195,263,852

31,342,350

Peter J. Zimetbaum, M.D.

194,954,297

31,651,905

Pierre Legault (Icahn Group nominee)

113,593,738

4,277,935

Dr. Eric J. Ende (Icahn Group nominee)

48,524,206

53,642,447

Andrew J. Fromkin (Icahn Group nominee)

41,957,886

60,208,767

Daniel A. Ninivaggi (Icahn Group nominee)

88,538,276

29,333,397

Proposal 2Advisory Vote on Executive Compensation. The stockholders approved (on an advisory basis) the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the 2012 Summary Compensation Table and the tabular disclosure regarding such compensation and the accompanying narrative disclosure.  IVS has advised the Company that there were no broker non-votes for Proposal 2.

For

Against

Abstain

183,934,926

40,974,304

1,696,971

Proposal 3Ratification of Independent Auditors. The stockholders ratified the appointment of BDO USA, LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending March 31, 2013.  IVS has advised the Company that there were no broker non-votes for Proposal 3.

For

Against

Abstain

223,855,004

1,575,909

1,175,288

Proposal 4Stockholder Proposal Regarding Proxy Access. The stockholders rejected the stockholder proposal requesting that the Board amend the Company’s Bylaws to allow stockholders to nominate director candidates for inclusion in the Company’s proxy materials.  IVS has advised the Company that there were no broker non-votes for Proposal 4.

For

Against

Abstain

21,393,262

154,609,317

50,603,622

 

 

 


 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:  August 21, 2012



 

Forest Laboratories, Inc.
(Registrant) 



 

/s/ Francis I. Perier, Jr.              
Francis I. Perier, Jr.
Executive Vice President Finance & Administration and
Chief Financial Officer